Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) CFO Donald T. Gardner III sold 3,000 shares of the business's stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $37.75, for a total transaction of $113,250.00. Following the completion of the transaction, the chief financial officer now owns 15,358 shares in the company, valued at approximately $579,764.50. The trade was a 16.34 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Kewaunee Scientific Stock Performance
Shares of KEQU stock opened at $33.24 on Friday. The firm has a 50 day moving average of $49.68 and a 200-day moving average of $47.36. The company has a market cap of $94.90 million, a price-to-earnings ratio of 5.27 and a beta of 0.59. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45. Kewaunee Scientific Co. has a 52 week low of $30.82 and a 52 week high of $71.33.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. The company had revenue of $67.17 million during the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded Kewaunee Scientific from a "buy" rating to a "hold" rating in a research note on Friday, March 14th.
Read Our Latest Analysis on KEQU
Hedge Funds Weigh In On Kewaunee Scientific
A number of institutional investors have recently modified their holdings of the company. Bank of America Corp DE grew its position in Kewaunee Scientific by 2,605.9% in the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after purchasing an additional 443 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock valued at $30,000 after buying an additional 900 shares during the last quarter. IFP Advisors Inc bought a new stake in shares of Kewaunee Scientific during the fourth quarter worth about $36,000. Morgan Dempsey Capital Management LLC acquired a new stake in shares of Kewaunee Scientific in the 4th quarter worth about $106,000. Finally, Barclays PLC bought a new position in Kewaunee Scientific in the 3rd quarter valued at about $121,000. 32.69% of the stock is owned by institutional investors and hedge funds.
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
